Bayer, Algeta win FDA approval for prostate cancer drug

FRANKFURT (Reuters) - German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros ($1.31 billion) in annual sales.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/krBxGLSHrCY/story01.htm

free phlebotomy training phlebotomy training in ny phlebotomy training ny